Anelixis Therapeutics
Cambridge, US · Founded 2015
Biotech
Founders & leadership
KB
Kent BransfordDirector
MM
Maeve McNallyExecutive Officer
TR
Theodore ReichDirector
SP
Steven PerrinExecutive Officer, Director
PS
Paul SallaberryDirector
AN
Augie NietoDirector
EC
Eric CravenDirector
JH
James HeywoodDirector
Reported raises · per SEC filings
Form D private placements$1MraisedMay 2019 · 10 investors · Biotechnology
Rule 506(b)$2.6MraisedApr 2018 · 6 investors · Biotechnology
Rule 506(b)$4.3MraisedJun 2017 · 4 investors · Biotechnology
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.